The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear

The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear

Peter Hansen/Getty Images

The US Food and Drug Administration says some people have been hospitalized with symptoms that may be related to overdoses from injectable weight-loss drugs.

No comments

Read more